Investment Notes: Eucalyptus | Blackbird
Summary
We were thrilled to invest into the round, having led the companys pre-seed round in January 2019, and seed round in October 2019.This is a hugely exciting milestone for cofounders, Tim Doyle, Charlie Gearside, Benny Kleist, and Alexey Mitko, and the whole team at Eucalyptus.The company launched its first product - Pilot - a medical advisor for a generation of young men that are poorly served by the medical community in July 2019.In January this year, Eucalyptus launched its second brand, Kin Fertility, to empower women with the information, products and access to health care they need to take control of their fertility. With that trust and loyalty comes the opportunity to build a suite of health services for Eucalyptus customers.There are very few healthcare brands that attract love and devotion. We think Eucalyptus can change this.Eucalyptus is built on a set of five distinct insights: There is an opportunity to create differentiated customer experience (CX) in healthcare through technology. Eucalyptus is building out a deeply talented group of people in pursuit of its mission.The superpower of doing what you say you willEucalyptus is one of those rare companies where the seed pitch deck predicted almost perfectly what theyd do in the following year. Since we first funded the company, theyve proved out two brands, hired an incredible team, and shown all the signs of efficiency we hoped to see in terms of their technology and customer experience.What holds those threads together is that Eucalyptus is ultimately a capital allocation business.Warren Buffet built Berkshire Hathaway by not investing more in the original textile mill.
Funding
Review available funding amount, funding date, investors, and linked company information related to Investment Notes: Eucalyptus | Blackbird in the interactive ISVWorld profile.